We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » EMA Confirms Suspension of Drugs Over Flawed Studies
EMA Confirms Suspension of Drugs Over Flawed Studies
June 11, 2015
The European Medicines Agency has confirmed plans to halt sales of 700 drug forms and strengths authorized based on clinical studies performed by Hyderabad, India-based GVK Biosciences.
